Skip to main content

Table 3 Unadjusted and adjusted analysis to assess adverse fetal and neonatal outcomes (Categorical) associated with GWG

From: The impact of gestational weight gain on fetal and neonatal outcomes: the Araraquara Cohort Study

Outcomes

Gestacional weight gain (IOM-2019)

Below

Above

Below

Above

Crude OR (IC95%)

Crude OR (IC95%)

Adjusted OR (IC95%)

Adjusted OR (IC95%)

Intrauterine growth restriction (FGR)

1.53 (1.11–2.10)

1.27 (0.92–1.74)

1.61 (1.14–2.27)

1.26 (0.89–1.78)

Prematurity

2.34 (1.81–3.02)

1.19 (0.91–1.57)

2.35 (1.81–3.05)

1.24 (0.94–1.64)

Apgar score at 5 minutes

0.58 (0.26–1.28)

0.34 (0.16–0.71)

0.52 (0.24–1.16)

0.42 (0.20–0.87)

Small for gestational age (SGA)

1.18 (0.92–1.50)

0.78 (0.60–1.01)

1.18 (0.92–1.53)

0.77 (0.59-1.00)

Large for gestational age (LGA)

0.43 (0.32–0.60)

1.54 (1.21–1.95)

0.38 (0.28–0.54)

1.53 (1.20–1.96)

Low birth weight (LBW)

2.32 (1.78–3.03)

1.17 (0.88–1.55)

2.44 (1.85–3.21)

1.21 (0.91–1.62)

  1. The association between each fetal or neonatal outcome and GWG. Analyses adjusted for: Maternal age; marital status; race/color; mothers’ education in years of study; BMI; gestational age in weeks; parity; number of rooms per person; lactose consumption; smoking; diabetes; serum levels of hemoglobin; glycated hemoglobin; cholesterol; triglycerides; HDL; LDL. Estimated odds ratios (OR) using a generalized estimating equation. OR, Odds Ratio; ORa, Adjusted Odds Ratio; CI, Confidence Interval